SCHEMBL25442286

SCHEMBL25442286

CC(C)C1CCN(C(=O)C2(Nc3ccccc3)CCC(N)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 5/20 0.41
▸ OPRM1 P35372 1/20 0.37
▸ CHRM2 P08172 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ ERAP1 Q9NZ08 1/20 0.36
▸ NAMPT P43490 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ EPHX2 P34913 2/20 0.36
▸ PARP1 P09874 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23903375 0.89 SMN1; SMN2 (0.44) OPRL1OPRM1ERAP1SMN1; SMN2NPC1
SCHEMBL25442296 0.89 SMN1; SMN2 (0.42) OPRL1OPRM1ERAP1SMN1; SMN2NPC1
SCHEMBL25442289 0.89 ERAP1 (0.39) ERAP1SMN1; SMN2NPC1TP53RAB9A
SCHEMBL25442273 0.88 SMN1; SMN2 (0.46) OPRL1ERAP1SMN1; SMN2PARP1ALDH1A1
SCHEMBL25442283 0.87 OPRL1 (0.40) OPRL1OPRM1SMN1; SMN2NPC1TP53
SCHEMBL23903361 0.86 NPSR1 (0.41) OPRL1OPRM1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL25443176 0.82 POLB (0.37) OPRL1OPRM1CHRM2CHRM1CHRM3
SCHEMBL25443129 0.82 MAPT (0.35) OPRL1OPRM1CHRM2CHRM1CHRM3
SCHEMBL25442278 0.81 GPR119 (0.50) NAMPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL25442297 0.80 EPHX2 (0.41) ERAP1SMN1; SMN2NPC1TP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142739-A1 PROTEIN-PROTEIN INTERACTION STABILIZERS UNIV CALIFORNIA (US) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142739-A1 PROTEIN-PROTEIN INTERACTION STABILIZERS HSPBP1, HSPA8, HSPH1 OPRL1 3718/4885OPRM1 4582/4885CHRM2 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback